Syros Pharmaceuticals (SYRS) Investor Presentation - Slideshow
SyrosSyros(US:SYRS)2023-05-18 15:24

SY-2101 in APL | --- | --- | --- | --- | |-----------------------------------------------------------------------------|-------------------------------------------------------------------------|----------------------------------------------|-------| | | | | | | Tamibarotene is a | selective and potent RARa agonist1 | Competitive differentiation of tamibarotene | | | | with tamibarotene | Biologically targeted1 | ✓ | | | | Oral | ✓ | | | | High complete response rates5,6 | ✓ | | of patients with HR-MDS are p ...